Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to test whether tesamorelin, in combination with a text-messaging
application to help with motivation and adherence, will significantly improve memory and
thinking in HIV.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Diego
Collaborators:
PalmTree Clinical Research Inc. University of California, San Francisco University of Southern California